APA (7th ed.) Citation

DEA, S., LS, S., MM, S., RR, A., AI, A. A., & SA, E. (2023). Interpretation of Farnesoid X Receptor Immunohistochemical Expression in Discriminating Hepatocellular Carcinoma from Its Non-Neoplastic Mimics as an Adjunct to Glypican 3. Asian Pacific journal of cancer prevention : APJCP, 24(9), 3221. https://doi.org/10.31557/APJCP.2023.24.9.3221

Chicago Style (17th ed.) Citation

DEA, Salama, Shash LS, Shakweer MM, Abdel-Maqsoud RR, Ahmed Abosaif AI, and Elgohary SA. "Interpretation of Farnesoid X Receptor Immunohistochemical Expression in Discriminating Hepatocellular Carcinoma from Its Non-Neoplastic Mimics as an Adjunct to Glypican 3." Asian Pacific Journal of Cancer Prevention : APJCP 24, no. 9 (2023): 3221. https://doi.org/10.31557/APJCP.2023.24.9.3221.

MLA (9th ed.) Citation

DEA, Salama, et al. "Interpretation of Farnesoid X Receptor Immunohistochemical Expression in Discriminating Hepatocellular Carcinoma from Its Non-Neoplastic Mimics as an Adjunct to Glypican 3." Asian Pacific Journal of Cancer Prevention : APJCP, vol. 24, no. 9, 2023, p. 3221, https://doi.org/10.31557/APJCP.2023.24.9.3221.